ONE-WAYOngoing theme · still written in the latest filings
Diagnostic technologies for early disease detection and individually optimized treatment
Development and rollout of diagnostic technologies and testing products that use core technologies such as flow cytometry, gene amplification, DNA chips and immunoassays to enable the early diagnosis and companion diagnosis of Alzheimer’s disease and cancer, as well as prediction of adverse drug reaction risks.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps2 helps · 0 hurts · 0 flat